ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
62 hedge funds and large institutions have $38.3M invested in Zynerba Pharmaceuticals, Inc in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $57.1M → $38.3M (-$18.8M)
Holders
62
Holding in Top 10
–
Calls
$875K
Puts
$521K
Top Buyers
| 1 | +$683K | |
| 2 | +$679K | |
| 3 | +$355K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$154K |
| 5 |
AGM
Alpine Global Management
New York
|
+$125K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$716K | |
| 3 | -$472K | |
| 4 |
Two Sigma Advisers
New York
|
-$196K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$146K |